92 In this mechanism, bacterial GSH is an essential cofactor, and mutants that are defective in GSH biosynthesis cannot inactivate fosfomycin, even though they possess the resistance gene
Evidence Summary There is currently insufficient evidence of consistent magnesium depletion directly caused by GLP-1 therapy
When I Start with Semaglutide Insurance covers Wegovy but not Zepbound (this is common, and its a valid reason)
Ejtahed et al., 2019
A significant increase in serum lipoprotein lipase (LPL) activity and a notable decrease in protein expression of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) were observed, demonstrated that the anti-lipidemic properties of EVP probably via regulation of hepatic LPL and HMGR ( Grifola frondosa polysaccharides (GFP) were proven to be capable of decreasing the levels of fasting blood glucose (FBG), oral glucose tolerance (OGT), TC, TG, and LDL-C in serum, and reducing the hepatic levels of TC, TG, and free fatty acids through inhibiting the expressions of SREBP-1c, ACC, Cd36, and HMGCR, and promoting the expressions of Acox1, Ldlr, CYP7A1, and BSEP in gene levels in high fat diet (HFD) and STZ-induced diabetic mice ( Dictyophora indusiate crude polysaccharides displayed hypolipidemic actions, including a decrease in fat accumulation and serum TG and free fatty acid levels by inhibiting the expressions of lipogenic genes, such as PPAR-, C/EBP, SREBP-1c, acetyl-CoA carboxylase-1 (ACC-1), and FAS ( Sarcodon aspratus could improve lipid metabolism in HFD-induced obese mice by regulating lipogenesis meditators (ACC-1 and PGC-1) ( Numerous animal and human clinical trial studies have demonstrated that dietary polysaccharides, such as plant polysaccharides, mushroom polysaccharides, and alga polysaccharides, have potential anti-hyperlipidemic effects ( G
